Showing 1 - 5 results of 5 for search 'Zhenfu Fu', query time: 0.03s Refine Results
  1. 1
    In Silico Investigation of the Molecular Mechanism of PARP1 Inhibition for the Treatment of BRCA-Deficient Cancers

    In Silico Investigation of the Molecular Mechanism of PARP1 Inhibition for the Treatment of BRCA-Deficient Cancers by Fengqin Yan, Zhenfu Fu, Guo Li, Zhiguo Wang

    Published 2023-02-01
    Get full text
    Article
  2. 2
    Effect of blood pressure on mortality in patients with cognitive impairment: a prospective cohort study

    Effect of blood pressure on mortality in patients with cognitive impairment: a prospective cohort study by YanChang Shang, ShuHui Wang, Chao Wei, ZhongBao Gao, HengGe Xie, ZhenFu Wang

    Published 2023-12-01
    Get full text
    Article
  3. 3
    Treatment Outcomes of 257 Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Nimotuzumab Plus Intensity-Modulated Radiotherapy with or without Chemotherapy: A Single-Institution Experience

    Treatment Outcomes of 257 Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Nimotuzumab Plus Intensity-Modulated Radiotherapy with or without Chemotherapy... by Fangzheng Wang, Chuner Jiang, Zhimin Ye, Tongxin Liu, Quanquan Sun, Fengqin Yan, Weifeng Qin, Zhenfu Fu, Yangming Jiang

    Published 2018-02-01
    Get full text
    Article
  4. 4
    Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma

    Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma by Zhimin Ye, Fangzheng Wang, Fengqin Yan, Lei Wang, Bin Li, Tongxin Liu, Fujun Hu, Mingxiang Jiang, Weiyang Li, Zhenfu Fu

    Published 2019-04-01
    Get full text
    Article
  5. 5
    Efficacy and Safety of Nimotuzumab Plus Radiotherapy With or Without Cisplatin-Based Chemotherapy in an Elderly Patient Subgroup (Aged 60 and Older) With Nasopharyngeal Carcinoma

    Efficacy and Safety of Nimotuzumab Plus Radiotherapy With or Without Cisplatin-Based Chemotherapy in an Elderly Patient Subgroup (Aged 60 and Older) With Nasopharyngeal Carcinoma by Fangzheng Wang, Chuner Jiang, Zhiming Ye, Quanquan Sun, Tongxin Liu, Min Xu, Peng Wu, Kaiyuan Shi, Bin Long, Zhenfu Fu, Yangming Jiang

    Published 2018-04-01
    Get full text
    Article

Search Tools: